Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017
Eric PF Chow, Sepehr N Tabrizi, Christopher K Fairley, Rebecca Wigan, Dorothy A Machalek, David G Regan, Jane S Hocking, Suzanne M Garland, Alyssa M Cornall, Steph Atchison, Catriona S Bradshaw, Anna McNulty, Louise Owen, Lewis Marshall, Darren B Russell, John M Kaldor, Marcus Y Chen
Vaccine | ELSEVIER SCI LTD | Published : 2019
BACKGROUND: Australia introduced a school-based human papillomavirus (HPV) vaccination program for females aged 12-13 years in 2007, with a three-year catch-up to age 26; and for boys aged 12-13 from 2013, with a two-year catch-up to age 15. This study aimed to compare the prevalence of penile HPV between teenage heterosexual males in cohorts eligible or non-eligible for the school-based male vaccination program. METHODS: Between 2014 and 2017, sexually active heterosexual males aged 17-19 were recruited from sexual health centres and community sources across Australia. Males provided a self-collected penile swab for 37 HPV genotypes using Roche Linear Array and completed a questionnaire. We..View full abstract
Awarded by Merck Co.
Awarded by Australian Government Department of Health
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:This study was funded by Merck & Co. (50939) and Australian Government Department of Health (HPV Surveillance Fund H1314G010).